摘要:
An antitumor agent against drug-fast tumors containing a compound represented by general formula (2) or (a) or a pharmacologically acceptable salt thereof as the active ingredient; wherein X represents Cl or Br; and R represents NR1R2 (wherein R?1 and R2¿ represent each independently hydrogen or C¿1?-C4 linear or branched alkyl) or a group of formula (b) (wherein R?3¿ represents CH¿2? or N-CH3). The agent has an excellent antitumor activity against drug-insensitive tumors and is useful as an antitumor agent against drug-fast tumors.
摘要:
It is intended to provide a method of inhibiting the formation of a soluble aggregate of an antibody in a solution; a method of inhibiting the formation of a chemically degraded product; and a method of stabilizing an antibody. It is also intended to provide a solution-type antibody preparation in which the formation of a soluble aggregate is inhibited; a solution-type antibody preparation in which the formation of a chemically degraded product is inhibited; a solution-type antibody preparation in which the formation of a soluble aggregate, the formation of a chemically degraded product and the formation of an insoluble aggregate are inhibited; an agent for inhibiting the formation of a soluble aggregate of an antibody; an agent for inhibiting the formation of a chemically degraded product of an antibody; and an antibody stabilizer.